Literature DB >> 32203681

Insulin access and affordability in the USA: anticipating the first interchangeable insulin product.

Jing Luo1, Aaron S Kesselheim2, Ameet Sarpatwari2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32203681      PMCID： PMC9036474          DOI： 10.1016/S2213-8587(20)30105-4

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  3 in total

1.  Cost-Related Insulin Underuse Among Patients With Diabetes.

Authors:  Darby Herkert; Pavithra Vijayakumar; Jing Luo; Jeremy I Schwartz; Tracy L Rabin; Eunice DeFilippo; Kasia J Lipska
Journal:  JAMA Intern Med       Date:  2019-01-01       Impact factor: 21.873

2.  Prices of Generic Drugs Associated with Numbers of Manufacturers.

Authors:  Chintan V Dave; Abraham Hartzema; Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2017-12-28       Impact factor: 91.245

3.  Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine.

Authors:  Vincent C Capati; Aaron S Kesselheim
Journal:  J Manag Care Spec Pharm       Date:  2016-04
  3 in total
  1 in total

1.  Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.

Authors:  Chana A Sacks; Victor L Van de Wiele; Lisa A Fulchino; Lajja Patel; Aaron S Kesselheim; Ameet Sarpatwari
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.